Editorial: Mechanisms and Novel Therapies in Graves' Orbitopathy: Current Update

Front Endocrinol (Lausanne). 2022 Apr 29:13:902591. doi: 10.3389/fendo.2022.902591. eCollection 2022.

Huifang Zhou^{1

2}, Ilaria Muller^{3

4

5}, Kelvin Kam-Lung Chong⁶, Marian Ludgate⁵, Sijie Fang^{1

2}

¹ Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
² Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
³ Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
⁴ Department of Endocrinology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁵ Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
⁶ Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

No abstract available

Keywords: epidemiology; evaluation; graves orbitopathy; novel therapeutic approach; pathogenesis.

Publication types